FASLG and hepatocellular carcinoma: In HCC, LINC00324 can promote the transcription of FasL by recruiting PU.1 to the FasL promoter region, up-regulating the level of FasL in liver cancer stem cells, inhibiting cell apoptosis, and promoting the occurrence and development of cancer (17).